Role of fungal infections in peritonitis;Stellenwert der mykosen bei intraabdominalen infektionen

Langenbeck's Archives of Surgery

Volumn 382, Issue 1 SUPPL., 1997, Pages

  Blinzler, L ^a   Fischer, K ^a   Just, H M ^a   Heuser, D ^a  

^a KLINIKUM NÜRNBERG   (Germany)

Author keywords

Antifungal therapy; Candidiasis; Fungal infection; Mycosis; Peritonitis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; TAUROLIDINE;

ANTIFUNGAL ACTIVITY; CANDIDIASIS; CONFERENCE PAPER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; PATHOPHYSIOLOGY; PERITONITIS; RISK FACTOR; TOTAL PARENTERAL NUTRITION;

ANTIFUNGAL AGENTS; CROSS INFECTION; DRUG THERAPY, COMBINATION; HUMANS; MYCOSES; PERITONITIS; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 0031439967     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Abi-Said D, Vartivarin SE, Bodey GP, Anaisie E (1995) Hematogenous Candidiasis - a review of therapeutic studies of fluconazol and amphotericin B and recommendations for management. J Mycol Med 5:217-224
2. British society for antimicrobial chemotherapy working party (1994) Management of deep candida infection in surgical and intensive care unit patients. ICMed 20:522-528
3. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P (1989) Clinical significance of candida isolated from peritoneum in surgical patients. Lancet 11:1437-1440
4. Diebel LN, Raafat AM, Dulchavsky SA, Brown WJ (1996) Gallbladder and biliary tract candidiasis. Surgery 120:760-765
5. Goldie SJ, Kiernan-Tridle L, Torres C, Gorban-Brenan N, Dunne D, Kliger AS, Finkelstein FO (1996) Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 28:86-91
6. Graybill JR (1996) The future of antifungal therapy. CID [Suppl 2] 22:166-178
7. Hariharan R, Weinstein RA (1995) Enterobactericeae. In: Mayhall CG (ed) Hospital epidemiology and infection control. Williams & Wilkins, Baltimore, pp 345-366
8. Kwon-Chung KJ, Bennett JE (1992) Medical mycology. Lea & Febiger Philadelphia, pp 280-336
9. Nösner K, Focht J (1994) In-vitro-Wirksamkeit von Taurolidin und 9 Antibiotika gegen klinische Isolate aus chirurgischem Einsendegut sowie gegen Pilze. Chir Gastroenterol [Suppl 2] 10: 80-89
10. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martínez- González J, Ibáñez-Lucia P, Torres-Rodríguez JM (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. ICMed 23: 23-30
11. Pederzoli P, Bassi C, Vesentini S, Campedelli A (1993) A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute pancreatitis. Surg Gynecol Obstet 176:480-483
12. Rook G (1991) Zellvermittelte Immunantwort. In: Roitt IM, Brostoff J, Male DK (Hrsg) Kurzes Lehrbuch der Immunologie. S 102-115
13. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P (1995) Pharmacokinetics in continuous renal replacement therapy. ICMed 21:612-620
14. Solomkin J, Flohr A, Quie PG, Simmons RL (1980) The role of candida in intraperitoneal infections. Surgery 80:524-530
15. Steinmetz HT (1996) Candidamykosen in der Intensivmedizin. Mykosen 1:1-19
16. Vincent J, Bihari DJ, Suter PM, Braining HA, White J, Nicolas-Chanoin M, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe - results of the European prevalence of infection in intensive care (EPIC) study. JAMA 274:639-644